GlassScriptPhysician profile
Robyn E Richmond
NPI 1427294560
$534.22
in general payments reported to CMS, 2019-2025
16 companies · $54.19 in 2025
The $54.19 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2022: $179 · 2023: $121 · 2024: $66.43 · 2025: $54.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $120.54 | 2019-2025 | Stravix, Oasis |
| Intuitive Surgical, INC. | $99.32 | 2022 | |
| Lifenet Health | $42.78 | 2023 | |
| Kls-Martin L.P. | $40.55 | 2019-2022 | |
| Heron Therapeutics, INC. | $25.98 | 2022 | |
| Integra Lifesciences Corporation | $23.75 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Vericel Corporation | $22.43 | 2025 | Nexobrid |
| Abbvie INC. | $19.65 | 2023 | |
| Z-Medica, LLC | $18.62 | 2019 | |
| Acell, INC. | $18.49 | 2019 | |
| Mallinckrodt Enterprises LLC | $18.40 | 2019 | |
| Portola Pharmaceuticals, LLC | $18.39 | 2019 | |
| Caris Mpi, INC. | $17.98 | 2025 | Mi Cancer Seek |
| W. L. Gore & Associates, INC. | $17.32 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Csl Behring | $17.08 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Richmond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.